Skip to main content

What the FDA labels say about taking them together

Disopyramide and propafenone

Disopyramide's FDA label of August 24, 2026 names propafenone in its warnings section; the propafenone label PlainMeds reads does not name disopyramide.

Check it at the source: the disopyramide FDA label on DailyMed (effective August 24, 2026, Pfizer Laboratories Div Pfizer Inc); the propafenone FDA label on DailyMed (effective September 1, 2025, Strides Pharma Science Limited).

What does the disopyramide label say about propafenone?

Disopyramide label, warnings

Concomitant Antiarrhythmic Therapy The concomitant use of Norpace or Norpace CR with other Type 1A antiarrhythmic agents (such as quinidine or procainamide), Type 1C antiarrhythmics (such as encainide, flecainide or propafenone), and/or propranolol should be reserved for patients with life-threatening arrhythmias who are demonstrably unresponsive to single-agent antiarrhythmic therapy.

Source: FDA drug label (Norpace), Pfizer Laboratories Div Pfizer Inc, effective August 24, 2026 (SPL set e2aa1642-d262-4520-bc6a-9fd3ad795677), via openFDA; the full label on DailyMed

What does the propafenone label say about disopyramide?

Propafenone's label (effective September 1, 2025) does not name disopyramide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (PROPAFENONE HYDROCHLORIDE), Strides Pharma Science Limited, effective September 1, 2025 (SPL set c65253ab-937f-4982-b841-69c2b9f9ccdb), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Disopyramide generic labelers
14Propafenone generic labelers
DisopyramidePropafenone
Labeled forn/aAtrial fibrillation
Boxed warningYesYes
Pharmacy cost (NADAC)$0.801 per capsule 100 mg capsule$0.115 per tablet 150 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?